Ema 40 mg (Capsule (Enteric Coated))
Unit Price: ৳ 10.00 (5 x 10: ৳ 500.00)
Strip Price: ৳ 100.00
Medicine Details
Category | Details |
---|---|
Generic | Esomeprazole |
Company | Globe pharmaceuticals ltd |
Also available as |
Indications
- Relief from chronic heartburn symptoms
- Healing of erosive esophagitis
- Maintenance of healing of erosive esophagitis
- Eradication of Helicobacter pylori infection
- Treatment of Zollinger-Ellison Syndrome
- Management of Acid-related Dyspepsia
- Treatment of Duodenal and Gastric ulcers
Pharmacology
- Proton pump inhibitor
- Suppression of gastric acid secretion
- Specific inhibition of the H+/K+-ATPase
- Single optical isomer providing better acid control
- Enteric-coated pellet formulation
- Metabolized in the liver by CYP enzymes
- Extensive protein binding
- Plasma elimination half-life of approximately 1-1.5 hours
Dosage
- Oral dosage form
- IV injection or IV infusion
- Different dosages for specific indications
- Adult and pediatric dosage specifications
- Dosage adjustments for hepatic insufficiency
Administration
- Instructions for tablet or capsule intake
- Guidelines for oral suspension
- Preparation and administration of IV injection solution
Interaction
- Metabolism by CYP2C19 and CYP3A4
- Potential interference with CYP2C19 substrates
- Possible impact on absorption of drugs affected by gastric pH
- Drug interaction studies with other medications
Contraindications
- Hypersensitivity to any of the formulation
Side effects
- Frequently occurring adverse events
- Headache
- Diarrhoea
- Nausea
- Flatulence
- Abdominal pain
- Constipation
- Dry mouth
Pregnancy lactation
- No adequate and well-controlled studies in pregnant women
- No teratogenic effects observed in animal studies
- Recommendation to discontinue breast-feeding if essential
Precautions warnings
- Symptomatic response does not exclude the presence of gastric malignancy
- Instructions for patients with difficulty swallowing capsules
- Usage of antacids
- Information for special patient groups (pediatric, geriatric, hepatic and renal insufficiency)
Use in special populations
- Safety and effectiveness in paediatric patients not established
- No overall differences in safety and efficacy in geriatric population
- No dosage adjustment recommended for mild to moderate hepatic insufficiency
- Pharmacokinetics not expected to be altered in renal impairment
Overdose effects
- Major signs of acute toxicity
- Symptomatic and supportive treatment recommended
- No specific antidote known
Storage conditions
- Recommended storage temperature and conditions
Chemical structure
- Molecular formula
- Chemical structure diagram
Commonly asked questions
- Information about the medication's uses and side effects
- Guidance for pregnant or breastfeeding individuals
- Duration for the medication to take effect
- Quick tips for usage
Related Brands
- Ema 20 mg (Capsule (Enteric Coated)) - globe-pharmaceuticals-ltd
- Esonix 20 mg/vial (IV Injection) - incepta-pharmaceuticals-ltd
- Esogap 20 mg (Capsule (Enteric Coated)) - euro-pharma-ltd
- Gaspro 20 mg (Capsule (Enteric Coated)) - ethical-drugs-limited
- Exome 20 mg (Tablet (Enteric Coated)) - chemist-laboratories-ltd